MI078
/ Nanjing Minowei Pharmaceutical Technology
- LARVOL DELTA
Home
Next
Prev
1 to 5
Of
5
Go to page
1
August 27, 2025
Efficacy of MI078 Capsules in Treating Postpartum Depression
(clinicaltrials.gov)
- P2 | N=72 | Active, not recruiting | Sponsor: Nanjing Minova Pharmaceutical Co., Ltd. | Recruiting ➔ Active, not recruiting
Enrollment closed • CNS Disorders • Depression • Mood Disorders • Postpartum Depression • Psychiatry
July 24, 2026
A Study of MI078 for Postpartum Depression
(clinicaltrials.gov)
- P3 | N=200 | Recruiting | Sponsor: Nanjing Minova Pharmaceutical Co., Ltd.
New P3 trial • CNS Disorders • Depression • Mood Disorders • Postpartum Depression • Psychiatry
May 21, 2025
A Study on the Safety, Pharmacokinetics, and Food Effects of MI078 Capsules
(clinicaltrials.gov)
- P1 | N=98 | Completed | Sponsor: Nanjing Minova Pharmaceutical Co., Ltd.
New P1 trial • CNS Disorders • Depression • Mood Disorders • Postpartum Depression • Psychiatry
May 09, 2025
Efficacy of MI078 Capsules in Treating Postpartum Depression
(clinicaltrials.gov)
- P2 | N=72 | Recruiting | Sponsor: Nanjing Minova Pharmaceutical Co., Ltd.
New P2 trial • CNS Disorders • Depression • Mood Disorders • Postpartum Depression • Psychiatry
June 25, 2026
Efficacy of MI078 Capsules in Treating Postpartum Depression
(clinicaltrials.gov)
- P2 | N=72 | Completed | Sponsor: Nanjing Minova Pharmaceutical Co., Ltd. | Active, not recruiting ➔ Completed | Trial completion date: Dec 2025 ➔ Aug 2025
Trial completion • Trial completion date • CNS Disorders • Depression • Mood Disorders • Postpartum Depression • Psychiatry
1 to 5
Of
5
Go to page
1